Effects of KB-2796 on plasma extravasation following antidromic trigeminal stimulation in the rat

Research Communications in Molecular Pathology and Pharmacology

Volumn 97, Issue 1, 1997, Pages 79-94

  Hashimoto, Munehiro ^a   Yamamoto, Yumi ^a   Takagi, Hiroshi ^a  

^a Tsukuba Research Laboratories   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CAPSAICIN; DIMETOTIAZINE MESYLATE; FLUNARIZINE; HISTAMINE; INDOMETACIN; LOMERIZINE; MEPYRAMINE MALEATE; NIFEDIPINE; PHOSPHORAMIDON; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDROMIC STIMULATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLUSTER HEADACHE; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIGRAINE; NOCICEPTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TRIGEMINAL NERVE;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CAPILLARY PERMEABILITY; CAPSAICIN; ELECTRIC STIMULATION; GLYCOPEPTIDES; INDOMETHACIN; MIGRAINE DISORDERS; PIPERAZINES; RATS; SKIN; TRIGEMINAL GANGLION;

EID: 0030839879     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. 2+ antagonist, on voltage-dependent Ca currents and oxidative metabolism in dissociated mammalian CNS neurons. Brain Res. 619: 263-270.
2. 1 in migraine and stress. Headache 16: 58-63.
3. Buzzi, M.G., Carter, W.B., Shimizu, T., Heath, H. III and Moskowitz, M.A. (1991). Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 30: 1193-1200.
4. Buzzi, M.G. and Moskowitz, M.A. (1990). The antimigraine drug, sumatriptan (GR43175), selective blocks neurogenic plasma extravasation from blood vessels in dura mater. Br. J. Pharmacol. 99: 202-206.
5. 1-like receptor agonist. Br. J. Pharmacol. 96: 379-387.
6. Couture, R. and Cuello, A.C. (1984). Studies on the trigeminal antidromic vasodilation and plasma extravasation in the rat. J. Physiol. 346: 273-285.
7. Devillier, P., Renoux, M., Giroud, J. and Regoli, D. (1985). Peptides and histamine release from rat peritoneal mast cell. Eur. J. Pharmacol. 117: 89-96.
8. Dimitriadou, V., Buzzi, M.G., Theoharides, T.C. and Moskowitz, M.A. (1992). Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience 48: 187-203.
9. Edvinsson, L. and Uddman, R. (1982). Immunohistochemical localization and dilatory effect of substance P on human cerebral vessels. Brain Res. 232: 466-471.
10. 2+ channel blocker, KB-2796, on 5-HT-induced responses. Folia. Pharmacol. Jpn. 104: 19-29. (Abst. in English).
11. Gamse, R., Holzer, P. and Lembeck, F. (1980). Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin. Br. J. Phamacol. 68: 207-213.
12. Goadsby, P.J., Edvinsson, L. and Ekman, R. (1990). Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol. 28: 183-187.
13. Hara, H., Harada, K. and Sukamoto, T. (1993). Chronological atrophy after transient middle cerebral artery occlusion in rats. Brain Res. 618: 251-260.
14. Hara, H., Ozaki, A., Yoshidomi, M. and Sukamoto, T. (1990). Protective effect of KB-2796, a new calcium antagonist, in cerebral hypoxia and ischemia. Arch. Int. Pharmacodyn. 304: 206-218.
15. + antagonist, KB-2796, on the regional cerebral blood flow and somatosensory evoked potentials in the ischemic brain in cats. Surg. Neurol. 30: 89-96.
16. Harada, K., Shiino, A., Matsuda, M. and Handa, J. (1989). Effects of a novel calcium antagonist, KB-2796, on neurologic outcome and size of experimental cerebral infarction in rats. Surg. Neurol. 32: 16-20.
17. Hashimoto, M., Shinozaki, Y. and Katori, M. (1993). Immediate inhibitory effect of methylprednisolone sulptanate (U-67590A) on antigen-induced cutaneous and airway responses in guinea-pigs. Br. J. Pharmacol. 108: 604-612.
18. Holmes, B., Brogden, R.N., Heel, R.C., Speight, T.M. and Avery, G.S. (1984). Flunarizine, a review of its pharmacodynamic and pharmacokinetics properties and therapeutic use. Drugs 27: 6-44.
19. 3H] nitrendipine binding. Jpn. J. Pharmacol. 48: 241-247.
20. Iwamoto, T., Morita, T. and Sukamoto, T. (1991). Calcium antagonism by KB-2796, a new diphenylpiperazine analogue, in dog vascular smooth muscle. J. Pharm. Pharmacol. 43: 535-539.
21. Kanazawa, T., Morita, T., Harada, K., Iwamoto, T., Ohtaka, H., Sukamoto, T., Ito, K. and Nurimoto, S. (1990). Selective effect of KB-2796, a new calcium entry blocker, on cerebral circulation: a comparative study of the effects of calcium entry blockers on cerebral and peripheral arterial blood flows. J. Cardiovasc. Pharmacol. 16: 430-437.
22. 2+ entry blocker, of the contractile response of isolated dog cerebral and peripheral arteries. Folia Pharmacol. Jpn. 89: 365-373. (Abstr. in English).
23. Lembeck, F. and Holzer, P. (1979). Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch. Pharmacol. 310: 175-183.
24. Markowitz, S., Saito, K. and Moskowitz, M.A. (1987). Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J. Neurosci. 7: 4129-4136.
25. Mayberg, M., Langer, R.S., Zervas, N.T. and Moskowitz, M.A. (1981). Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headache in man. Science 213: 228-230.
26. Middlemiss, D.N., Bremer, M.E. and Smith, S.M. (1988). A pharmacological analysis of the 5-HT receptor mediating inhibition of 5-HT release in the guinea pig frontal cortex Eur. J. Pharmacol. 157: 101-107.
27. Moskowitz, M.A. (1992). Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Phamacol. Sci. 13: 307-311.
28. Moskowitz, M.A. and Buzzi, M.G. (1991). Neuroeffector functions of sensory fibers: implications for headache mechanisms and drug actions. J. Neurol. 238: S18-S22.
29. Moskowitz, M.A., Brody, M. and Liu-Chen, L.Y. (1983). In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid. Neuroscience 9: 809-814.
30. O'Connor, T.P. and van der Kooy, D. (1988). Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J. Neurosci. 8: 2468-2476.
31. Ollat, H. (1992). Serotonin agonists and antagonists in migraine headache. Path. Biol. 40: 389-396.
32. 2+ channel blockers on cortical hypoperfusion and expression of c-Fos-like immunoreactivity after cortical spreading depression in rats. Br. J. Pharmacol. 115: 1359-1368.
33. Skofitsh, G., Savitt, J.M. and Jacobowitz, D.M. (1985). Suggestive evidence for a functional unit between mast cells and substance P fibers in the rat diaphragm and mesentery. Histochemistry 82:5-8.
34. Sleight, A.J., Cevenka, A. and Peroutka, S.J. (1990). In vivo effects of sumatriptan (GR43175) on extracellular levels of 5-HT in guinea pig. Neuropharmacology 29: 511-513.
35. Wasserman, S.I. (1987). The regulation of inflammatory mediator production by mast cell products. Am. Rev. Respir. Dis. 135: S46-S48.
36. Yamashita, A., Ozaki, A., Ikegami, A., Hayashi, A., Hara, H., Sukamoto, T. and Ito, K. (1993). Effects of a new diphenylpiperazine calcium antagonist, KB-2796, on cerebral ischemic neuronal damage in rats. Gen. Phamac. 24: 1473-1480.
37. Yoshidomi, M., Hayashi, T., Abe, K. and Kogure, K. (1989). Effects of a new calcium channel blocker, KB-2796, on protein synthesis of the CA1 pyramidal cell and delayed neuronal death following transient forebrain ischemia. J. Neurochem. 53: 1589-1594.